SCHEMBL7495667

SCHEMBL7495667

CCOC(=O)c1nc(Cl)c2cc(Cl)ccc2n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.54
MEN1 O00255 4/20 0.54
ADORA2A P29274 1/20 0.50
ALDH1A1 P00352 3/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
MAPT P10636 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
GAA P10253 2/20 0.46
NPY1R P25929 1/20 0.46
NPY2R P49146 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
GPR55 Q9Y2T6 1/20 0.46
MAOB P27338 1/20 0.46
ALOX15 P16050 1/20 0.46
MAPK10 P53779 1/20 0.46
SCN9A Q15858 1/20 0.45
CYP1A2 P05177 1/20 0.45
HPGD P15428 1/20 0.45
XBP1 P17861 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3287907 0.89 KDM4E (0.53) KMT2AMEN1ALDH1A1L3MBTL1MAPT
SCHEMBL20352238 0.88 KMT2A (0.53) KMT2AMEN1ADORA2AALDH1A1L3MBTL1
SCHEMBL163631 0.86 TSHR (0.52) KMT2AMEN1ALDH1A1L3MBTL1MAPT
SCHEMBL3996643 0.85 SHMT2 (0.54) KMT2AMEN1ALDH1A1MAPTSMN1; SMN2
SCHEMBL30629540 0.84 PLA2G2A (0.52) KMT2AMEN1ALDH1A1SMN1; SMN2HPGD
SCHEMBL161315 0.83 SMN1; SMN2 (0.61) KMT2AMEN1ALDH1A1L3MBTL1MAPT
SCHEMBL28601041 0.80 ALDH1A1 (0.52) KMT2AMEN1ADORA2AALDH1A1L3MBTL1
SCHEMBL164778 0.80 KMT2A (0.50) KMT2AMEN1ADORA2AMAPTSMN1; SMN2
SCHEMBL166288 0.78 TSHR (0.52) KMT2AMEN1ALDH1A1L3MBTL1MAPT
SCHEMBL163006 0.78 KMT2A (0.42) KMT2AMEN1ALDH1A1L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607439-B1 NITROGENOUS HETEROCYCLIC COMPOUND EISAI CO LTD (JP) 2002-01-09 EP disclosed
US-6046206-A Method of treating a patient having a precancerous lesions with amide quinazoline derivatives CELL PATHWAYS, INC. (US) 2000-04-04 US disclosed
US-5801180-A ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS EISAI CO., LTD. (JP) 1998-09-01 US disclosed
US-5693652-A Benzimidazoles for ischemic heart conditions EISAI CO., LTD. (JP) 1997-12-02 US disclosed
US-5576322-A Anti-ischemic 2,4-diaminoquinazolines EISAI CO., LTD. (JP) 1996-11-19 US disclosed
EP-0607439-A1 NITROGENOUS HETEROCYCLIC COMPOUND Eisai Co., Ltd. (JP) 1994-07-27 EP disclosed